Biomea Fusion Reports New Preclinical Data on Icovamenib-Semaglutide Combination Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. ADYYF
10. DVLT

Go back to Biomea Fusion Reports New Preclinical Data on Icovamenib-Semaglutide Combination Study
(NASDAQ: BMEA) Delayed: 1.32 +0.04 (3.13%)
Previous Close $1.28    52 Week High $ 
Open $1.27    52 Week Low $ 
Day High $1.34    P/E N/A 
Day Low $1.26    EPS $ 
Volume 424,204